Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yijing granules for premature ovarian insufficiency (kidney deficiency and liver depression pattern)
CTR20200836Phase 2Active
- Sponsor
- Nanjing Dadong Pharmaceutical Technology
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yijing Granules in ovarian hypofunction (POI), sponsored by Nanjing Dadong Pharmaceutical Technology. Started Jun 2020; status: active.
02
Drugs
Yijing Granules
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on CTR20200836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200836.